Skip to main content

Akzo Nobel N.V.

corporate_fare Company Profile

Akzo Nobel N.V.

AKZOY·OTC·Industrial Applications And Services·CIK 0000003124

Akzo Nobel N.V. is a diversified, multicultural, and global company with operations in human and animal healthcare, coatings, and chemicals. The company's operations are organized into segments based on the affinity between activities. These segments include Human Pharmaceuticals (Organon) and Animal Health (Intervet), which are collectively referred to as Pharma, as well as Coatings and Chemicals. Within the Coatings and Chemicals segment, activities are carried out in specific business units. The Board of Management is responsible for the company's management, including defining strategic direction, establishing policies, and overseeing day-to-day operations. Key tasks at the corporate level are coordinated across various fields, including strategy, finance, control, human resources, technology, legal affairs and intellectual property, communications, health, safety, and environment, information management, and risk and insurance management. The company's strategy focuses on building sustainable leading business positions, aiming for attractive growth, returns significantly above the costs of capital, and substantial operational cash flows. Akzo Nobel actively restructures and divests activities that do not meet its criteria. The company develops competitive advantages by combining a customer focus and entrepreneurial spirit from its decentralized business unit organization with the scale of a global organization, providing access to global capital markets, managerial talent, best management practices, and purchasing power.

Akzo Nobel N.V. (OTC:AKZOY) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 1 item for AKZOY at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-07-13, rated 7/10. Recent SEC coverage for AKZOY spans 6-K.

Recent high-impact activity:

  • Russian Presidential Decree Places AkzoNobel Subsidiaries Under Temporary External Administration

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 201,937 shares in AKZOY as of the September 15, 2026 settlement, a 12.6% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On October 2, 2026, 16.0% of AKZOY volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)201,937 shares as of September 15, 2026
Change vs prior period▲ 12.6%
Days to cover1.00 at avg daily volume of 657,150
Daily short volume (FINRA facilities)16.0% of 85,273 shares on October 2, 2026
5-day average short volume15.5%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Insider Transactions

AKZOY files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

$21.18 +0.20% today
52-week range · as of 2026-07-13 $18.04 – $25.99
Market cap
$10.92B
Volume
86.1K (0.4× avg)
3-mo avg 231.6K
Live data · 2026-10-05 02:50 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed AKZOY - Latest Insights

AKZOY
Jul 13, 2026, 3:25 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $21.76
Real-time Price: $21.18 info
Change: -$0.580 (-3%) info
Market Cap: $10.921B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets